Renal allograft outcome from cytomegalovirus seronegative donor into cytomegalovirus seronegative recipient: poor prognosis after seroconversion.
Besse
T
T
Department of Renal Transplantation Cliniques Universitaires Saint-Luc, Brussels, Belgium.
Malaise
J
J
De Meyer
M
M
Mourad
M
M
Squifflet
J P
JP
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use; D003586:Cytomegalovirus Infections / Q000453:epidemiology*; D005500:Follow-Up Studies; D015774:Ganciclovir / Q000627:therapeutic use; D006084:Graft Rejection / Q000453:epidemiology*; D006085:Graft Survival; D006650:Histocompatibility Testing; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology / Q000401:mortality / Q000502:physiology*; D019520:Living Donors; D016035:Pancreas Transplantation; D011183:Postoperative Complications / Q000453:epidemiology*; D011379:Prognosis; D012189:Retrospective Studies; D016019:Survival Analysis; D013997:Time Factors; D014019:Tissue Donors
D000998:Antiviral Agents; D015774:Ganciclovir